Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUM159PT | TNBC | Basal B | Carboplatin | DNA cross-linker | DNA cross-linker | 0.0862 | uM | 7920.075 | 0.9365 | 0.9715 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Gemcitabine | DNA replication | DNA replication | 1.16 | uM | 7920.075 | 0.0593 | 0.0790 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Carboplatin | DNA cross-linker | DNA cross-linker | 0.00345 | uM | 7920.075 | 0.9726 | 0.9879 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Gemcitabine | DNA replication | DNA replication | 5.78 | uM | 7920.075 | 0.0527 | 0.0517 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Carboplatin | DNA cross-linker | DNA cross-linker | 0.0172 | uM | 7920.075 | 0.9781 | 0.9904 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Gemcitabine | DNA replication | DNA replication | 28.9 | uM | 7920.075 | 0.0510 | 0.0442 | 4.5785 | |
| SUM159PT | TNBC | Basal B | Carboplatin | DNA cross-linker | DNA cross-linker | 0.431 | uM | 7920.075 | 1.0011 | 1.0005 | 4.5785 |